Disclosure/conflict of interest

The ASBMR is committed to ensuring the balance, independence, objectivity and scientific rigor of all its individually sponsored or industry-supported educational activities. Accordingly, the ASBMR adheres to the requirement set by the Federation of American Societies for Experimental Biology (FASEB) that audiences at FASEB-sponsored educational programs be informed of a presenter's (speaker, faculty, author, or contributor) academic and professional affiliations, and the disclosure of the existence of any significant financial interest or other relationship a presenter has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during the presentation, it is required that presenters disclose that the product is not labeled for the use under discussion or that the product is still investigational. This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented. The Program will note those speakers who have disclosed relationships, including the nature of the relationship and the associated commercial entity.

All authors of submitted abstracts completed the disclosure statement in the online submission program. Invited speakers who are not required to submit an abstract received a form that they completed and returned.

Disclosure includes any relationship that may bias one's presentation or which, if known, could give the perception of bias. This includes relevant financial relationships of a spouse or partner. These situations may include, but are not limited to:

DISCLOSURE KEY

• 1) 
  stock options or bond holdings in a for-profit corporation or self-directed pension plan
• 2) 
  research grants
• 3) 
  employment (full or part-time)
• 4) 
  ownership or partnership
• 5) 
  consulting fees or other remuneration
• 6) 
  non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
• 7) 
  receipt of royalties
• 8) 
  speaker's bureau
• 9) 
  other

Disclosures for invited speakers and abstract presenters are provided at the end of the session listing for invited speakers (see On-Site Program book) and directly after the body of an abstract for abstract submissions. If there is no conflict of interest or disclosure listed, this means that the invited speaker and/or abstract presenter indicated no conflicts to disclose.

The disclosure information will correspond to the key above. If disclosures are given, the company name, along with the respective disclosure relationship number will be listed (for example: Company Name, 2, 8.). 

Table  . ABSTRACTS KEY

1001–1300	Concurrent Oral Presentation
O#	Oral Poster Presentation
S#	Sunday Plenary Poster Presentation
M#	Monday Poster Presentation
T#	Tuesday Poster Presentation
W#	Wednesday Poster Presentation
*(Asterisk)	Denotes Non-ASBMR Membership